ITC Judge Pushes For Import Ban In Liver Drug Secrets Row
The U.S. International Trade Commission's chief judge is recommending the agency block a Hong Kong drug developer from potentially marketing unapproved treatments for a type of liver disease for the next...To view the full article, register now.
Already a subscriber? Click here to view full article